Product
Quadrivalent Influenza mRNA Vaccine MRT5421
1 clinical trial
1 indication
Indication
Influenza ImmunizationClinical trial
A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and AboveStatus: Recruiting, Estimated PCD: 2025-05-22